TGH Stock Overview
Engages in the research, development, production, and sale of biological products for the agriculture sector in Australia and New Zealand.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Terragen Holdings Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.011 |
52 Week High | AU$0.036 |
52 Week Low | AU$0.009 |
Beta | -0.60 |
11 Month Change | -38.89% |
3 Month Change | -47.62% |
1 Year Change | -50.00% |
33 Year Change | -96.27% |
5 Year Change | n/a |
Change since IPO | -94.50% |
Recent News & Updates
Recent updates
Shareholder Returns
TGH | AU Chemicals | AU Market | |
---|---|---|---|
7D | 0% | 1.1% | -0.3% |
1Y | -50.0% | 0.4% | 8.3% |
Return vs Industry: TGH underperformed the Australian Chemicals industry which returned 0.4% over the past year.
Return vs Market: TGH underperformed the Australian Market which returned 8.3% over the past year.
Price Volatility
TGH volatility | |
---|---|
TGH Average Weekly Movement | n/a |
Chemicals Industry Average Movement | 10.9% |
Market Average Movement | 8.2% |
10% most volatile stocks in AU Market | 16.3% |
10% least volatile stocks in AU Market | 3.2% |
Stable Share Price: TGH's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine TGH's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | n/a | Richard Norton | www.terragen.com.au |
Terragen Holdings Limited engages in the research, development, production, and sale of biological products for the agriculture sector in Australia and New Zealand. It offers Mylo, a microbial feed supplement for animals; and Great Land Plus, a liquid biological soil conditioner that enhances soil characteristics. The company was incorporated in 1996 and is based in Coolum Beach, Australia.
Terragen Holdings Limited Fundamentals Summary
TGH fundamental statistics | |
---|---|
Market cap | AU$4.43m |
Earnings (TTM) | -AU$2.53m |
Revenue (TTM) | AU$2.58m |
1.7x
P/S Ratio-1.7x
P/E RatioIs TGH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
TGH income statement (TTM) | |
---|---|
Revenue | AU$2.58m |
Cost of Revenue | AU$88.33k |
Gross Profit | AU$2.49m |
Other Expenses | AU$5.03m |
Earnings | -AU$2.53m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.0069 |
Gross Margin | 96.58% |
Net Profit Margin | -98.12% |
Debt/Equity Ratio | 0% |
How did TGH perform over the long term?
See historical performance and comparison